The use of TNF-α blockers in Cogan's syndrome [2]

Rheumatology International

Volumn 27, Issue 10, 2007, Pages 995-996

  Touma, Zahi ^a   Nawwar, Rita ^b   Hadi, Usamah ^a   Hourani, Mukbil ^a   Arayssi, Thurayya ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Endocrinology and Metabolism Division   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUDIOGRAPHY; COCHLEA PROSTHESIS; COGAN SYNDROME; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEARING LOSS; HUMAN; LABORATORY TEST; LETTER; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SLIT LAMP; THORAX RADIOGRAPHY; TINNITUS; VERTIGO; VOMITING;

EID: 34447520466     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0373-y     Document Type: Letter

References (1)

1. Fricker M et al (2006) A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int